Possible Solution to Corneal Transplant Rejection
Lymphatic vessels, shown in green, can overgrow in response to a corneal transplant. Credit: Wei-Sheng Chen, Tufts University School of Medicine
A team that included RPB-supported researchers at Tufts University School of Medicine has successfully prevented corneal inflammation, a condition that contributes to corneal tissue transplantation rejection, by inhibiting the overgrowth of lymphatic vessels.
The findings, published in Nature Communications, may have wider impact because the same overgrowth of lymphatic vessels, called Lymphangiogenesis, occurs in organ transplant rejection, cancer metastasis, lymphatic obstruction, complications of diabetes and hypertension.
April 13, 2016
Related News: Cornea , Infectious Eye Disease, Top Story
The Time is Now to Protect the National Eye Institute
The existence of the National Eye Institute, the most important source of funding for vision research in the U.S., is being threatened.
RPB Grantees Contribute to Eye Transplantation Effort
The ARPA-H THEA project takes on an exciting challenge.
Research to Prevent Blindness Opens Applications for Vision Research Grants
The awards offered cover a wide variety of topics in vision science, including glaucoma, age-related macular degeneration, retinal diseases, and many more.
Subscribe
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
| General Info | Grants | News & Resources |
Research to Prevent Blindness
360 Lexington Avenue, 22nd Floor
New York, NY 10017
(212) 752-4333
Copyright © 2024 Research to Prevent Blindness. All Rights Reserved.
